Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients


Submitted: May 23, 2016
Accepted: September 3, 2016
Published: March 31, 2017
Abstract Views: 2299
PDF: 1260
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

  • Levent Ozcan Department of Urology, Derince Training and Research Hospital, Kocaeli, Turkey.
  • Huseyin Besiroglu Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Murat Dursun Department of Urology, Bahcelievler State Hospital, Istanbul, Turkey.
  • Emre Can Polat Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Alper Otunctemur Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
  • Emin Ozbek Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Objective: We evaluated the correlation between benign prostate hyperplasia (BPH) measures and diabetes mellitus in men with benign prostate hyperplasia in a prospective study. Materials and methods: Between 2008-2012, 100 diabetic and 200 non diabetic patients undergoing surgery due to benign prostate hyperplasia were enrolled in the study. The parameters evaluated for each patients included prostate volume, fasting blood glucose, HbA1c, total testosterone, total prostatic specific antigen (T-PSA), triglicerides, total cholesterol and body mass index (BMI). A questionnaire including international prostate symptom score (IPSS) was sdministered and uroflow test measuring the peak urinary flow rate was performed to appreciate the complaints of the patients objectively. Results: Diabetic patients are more likely to have larger prostate volume. The symptom score evaluated by IPSS and post micturition residual volume were also significantly higher in diabetic groups. The other statistically significant different parameter between two groups was total testosterone that diabetic patients tend to have lower levels. Diabetic counterparts were established to have higher BMI. No statistically significant differentiation was observed about trigliceryde and total cholesterol levels and uroflow rates. Conclusions: Our study suggests a positive correlation between high prostate volume and diagnosis of diabetes mellitus in patients with benign prostatic hyperplasia. We also observed a positive correlation between symptom scores and post micturion residual volumes and diagnosis of diabetes mellitus suggesting that the presence of diabetes is related to both static and dynamic components of benign prostate hyperplasia. Additionally testosterone levels were lower in diabetic patients. Further studies need to confirm these relationship in a larger population.

Supporting Agencies

none

Ozcan, L., Besiroglu, H., Dursun, M., Polat, E. C., Otunctemur, A., & Ozbek, E. (2017). Comparison of the clinical parameters of benign prostate hyperplasia in diabetic and non diabetic patients. Archivio Italiano Di Urologia E Andrologia, 89(1), 26–30. https://doi.org/10.4081/aiua.2017.1.26

Downloads

Download data is not yet available.

Citations